COVID-19 patients are more susceptible to Mucormycosis due to prolonged steroid use, immunomodulator use, high ferritin levels, acidosis in DIABETIC KETO ACIDOSIS and CHRONIC KIDNEY DISEASE, prolonged antibiotic use. This disease carries high morbidity and mortality. This includes loss of eye – exenteration. Cost of treatment is high. Liposomal Ampho-B treatment costs almost 12000-15000 Rs/ day. Posaconazole is also a costly alternative. Hence, all efforts must be done to prevent it, diagnose it at early stage, and manage effectively. Predisposing Factors:- · Uncontrolled Diabetes Mellitus · Immunosuppression by steroids · Treatment with Immunomodulators – Tocilizumab, Itolizumab, etc. · Prolonged ICU stay · Long standing oxygen therapy – specially by nasal prongs · Comorbidities – post-transplant, malignancies · Voriconazole therapy · Long term Ryles tube feeding · Humidifier bottle contamination